| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.COVIRO.2017.04.002 |
| P8608 | Fatcat ID | release_54vu6naqyzevzeiko2gghpy7te |
| P698 | PubMed publication ID | 28486135 |
| P50 | author | Gavin R Screaton | Q42305839 |
| P2093 | author name string | Iris Scherwitzl | |
| Juthathip Mongkolsapaja | |||
| P2860 | cites work | Recognition determinants of broadly neutralizing human antibodies against dengue viruses | Q27697333 |
| Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever | Q29619585 | ||
| A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus | Q35654743 | ||
| Zika Virus Associated with Microcephaly | Q22683189 | ||
| Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study | Q23012849 | ||
| The global distribution and burden of dengue | Q24628768 | ||
| Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus | Q24737245 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 95-101 | |
| P577 | publication date | 2017-05-06 | |
| P1433 | published in | Current opinion in virology | Q26842394 |
| P1476 | title | Recent advances in human flavivirus vaccines | |
| P478 | volume | 23 |
| Q51336360 | A systematic approach to the development of a safe live attenuated Zika vaccine. |
| Q59360236 | An Industry Perspective on Dengue Drug Discovery and Development |
| Q83225458 | Broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomics |
| Q52725492 | Dengue viruses cleave STING in humans but not in nonhuman primates, their presumed natural reservoir. |
| Q63246464 | Key Amino Acid Substitution for Infection-Enhancing Activity-Free Designer Dengue Vaccines |
| Q92842972 | Kyasanur Forest Disease in India: innovative options for intervention |
| Q90014848 | Long non-coding subgenomic flavivirus RNAs have extended 3D structures and are flexible in solution |
| Q47202176 | Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage |
| Q57789690 | The Small-Compound Inhibitor K22 Displays Broad Antiviral Activity against Different Members of the Family Flaviviridae and Offers Potential as a Panviral Inhibitor |
| Q58569778 | The immune response against flaviviruses |
| Q51336389 | The immunology of Zika Virus. |
| Q99575005 | The role of capsid in the flaviviral life cycle and perspectives for vaccine development |
| Q92215826 | West Nile virus vaccines - current situation and future directions |
| Q61053781 | What is the Value of Different Zika Vaccination Strategies to Prevent and Mitigate Zika Outbreaks |
| Q91912294 | Zoonosis: Update on Existing and Emerging Vector-Borne Illnesses in the USA |
Search more.